SCHEMBL8015149

SCHEMBL8015149

[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na].[Na]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9694838 1.00
SCHEMBL2675782 1.00
SCHEMBL679489 1.00
SCHEMBL7804 1.00
SCHEMBL1890701 1.00
SCHEMBL8661925 1.00
SCHEMBL131783 1.00
SCHEMBL21774 1.00
SCHEMBL8420181 1.00
SCHEMBL11234658 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0791006-B1 POLYANIONIC BENZYLGLYCOSIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION AMERICAN HOME PROD (US) 2000-01-26 EP claimed
EP-0791006-A2 POLYANIONIC BENZYLGLYCOSIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION AMERICAN HOME PRODUCTS CORPORATION (US) 1997-08-27 EP claimed
WO-1996014323-A1 POLYANIONIC BENZYLGLYCOSIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION AMERICAN HOME PRODUCTS CORPORATION (US) 1996-05-17 WO claimed
US-4407796-A IMMUNOLOGY AMERICAN CYANAMID COMPANY (US) 1983-10-04 US claimed
EP-0082927-A1 Salts of polyhexaose sulfate derivatives as modulators of the complement system AMERICAN CYANAMID COMPANY (US) 1983-07-06 EP claimed
US-4359458-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1982-11-16 US claimed
US-4247535-A Modified cyclodextrin sulfate salts as complement inhibitors AMERICAN CYANAMID COMPANY (US) 1981-01-27 US claimed
US-4221907-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1980-09-09 US claimed
WO-2024076934-A2 COMPOSITIONS AND METHODS FOR MODULATION OF CFTR CYSTIC FIBROSIS FOUNDATION (US) 2024-04-11 WO disclosed
WO-2024026122-A2 COMPOUNDS FOR TREATMENT OF CONDITIONS AND DISEASES STOKE THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed
US-20230116704-A1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES STOKE THERAPEUTICS, INC. 2023-04-13 US disclosed
WO-2021113541-A1 ANTISENSE OLIGOMERS FOR TREATMENT OF CONDITIONS AND DISEASES STOKE THERAPEUTICS, INC. (US) 2021-06-10 WO disclosed
EP-0791006-B1 POLYANIONIC BENZYLGLYCOSIDES AS INHIBITORS OF SMOOTH MUSCLE CELL PROLIFERATION AMERICAN HOME PROD (US) 2000-01-26 EP disclosed
US-5830920-A PREVENTION GROWTH OF SMOOTH MUSCLE CELLS HOFFMANN-LA ROCHE INC. (US) 1998-11-03 US disclosed
EP-0082927-A1 Salts of polyhexaose sulfate derivatives as modulators of the complement system AMERICAN CYANAMID COMPANY (US) 1983-07-06 EP disclosed
US-4359458-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1982-11-16 US disclosed
US-4258180-A C6-Modified cyclodextrin sulfate salts as complement inhibitors AMERICAN CYANAMID COMPANY (US) 1981-03-24 US disclosed
US-4247535-A Modified cyclodextrin sulfate salts as complement inhibitors AMERICAN CYANAMID COMPANY (US) 1981-01-27 US disclosed
US-4232150-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1980-11-04 US disclosed
US-4221907-A COMPLEMENT INHIBITORS AMERICAN CYANAMID COMPANY (US) 1980-09-09 US disclosed